MedPath

ILARIS

ILARIS

Discontinued
DIN Number

02344939

Drug Class

Human

Market Date

Apr 27, 2010

Company
HC

novartis pharmaceuticals canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02344939
AIG Number0152696001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
L04AC08 CANAKINUMAB
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationSubcutaneous
AHFS Classification90:28.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

CANAKINUMABActive
Strength: 150 MG / VIAL
Monograph: CANAKINUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.